Yasuo Hamamoto

10PUBLICATIONS
46CO-AUTHORS
Econometric and statistical methodsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 21, 2025
A discrete choice experiment to assess treatment preferences for patients with esophageal cancer in Japan.

Yasuo Hamamoto, Akihiko Inagawa, Tsunehisa Yamamoto

|Jul 06, 2025
ONO-4578 Plus Nivolumab in Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer.

Akihito Kawazoe, Kensei Yamaguchi, Tetsuya Hamaguchi

|Jan 11, 2025
Dynamic Changes in Circulating Tumor DNA During Immunotherapy for Head and Neck Cancer: SHIZUKU-HN Study.

Rika Noji, Kohki Tohyama, Shin Nakamura

|Mar 30, 2023
Efficacy of Targeted Trials and Signaling Pathway Landscape in Advanced Gastrointestinal Cancers From SCRUM-Japan GI-SCREEN: A Nationwide Genomic Profiling Program.

Yoshiaki Nakamura, Riu Yamashita, Wataru Okamoto

|May 05, 2022
Management of elderly patients with esophageal squamous cell cancer.

Yasuo Hamamoto, Kentaro Murakami, Ken Kato

|Mar 16, 2022
Three-Year Follow-Up and Response-Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3).

Morihito Okada, Ken Kato, Byoung Chul Cho

Pageof 2

Frequent Collaborators

3 joint publications

Ken Kato

2 joint publications

Keitaro Shimozaki

2 joint publications

Eiji Oki

1 joint publications

Chiyo K Imamura